| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Wellcome Trust Centre for Cell-Matrix Research (G.C., A.W., R.P.B.-H., A.E.C.), School of Biological Sciences, and the Cardiovascular Research Group (G.C., M.Y.A., V.O., J.O., A.E.C.), School of Medicine, University of Manchester, Manchester, UK; the Department of Pharmacology (B.C.V.), Amgen Inc, Thousand Oaks, Calif; and the Department of Genetics and Developmental Biology (Y.-W.F.), University of Connecticut Health Center, Farmington, Conn.
Correspondence to Dr Ann E Canfield, University of Manchester, Wellcome Trust Centre for Cell-Matrix Research, 2.205, Stopford Building, Oxford Road, Manchester M13 9PT, UK. E-mail ann.canfield{at}man.ac.uk
Vascular pericytes undergo osteogenic differentiation in vivo and in vitro and may, therefore, be involved in diseases involving ectopic calcification and osteogenesis. The purpose of this study was to identify factors that inhibit the entry of pericytes into this differentiation pathway. RNA was prepared from pericytes at confluence and after their osteogenic differentiation (mineralized nodules). Subtractive hybridization was conducted on polyA PCR-amplified RNA to isolate genes expressed by confluent pericytes that were downregulated in the mineralized nodules. The subtraction product was used to screen a pericyte cDNA library and one of the positive genes identified was Axl, the receptor tyrosine kinase. Northern and Western blotting confirmed that Axl was expressed by confluent cells and was downregulated in mineralized nodules. Western blot analysis demonstrated that confluent pericytes also secrete the Axl ligand, Gas6. Immunoprecipitation of confluent cell lysates with an anti-phosphotyrosine antibody followed by Western blotting using an anti-Axl antibody, demonstrated that Axl was active in confluent pericytes and that its activity could not be further enhanced by incubating the cells with recombinant Gas6. The addition of recombinant Axl-extracellular domain (ECD) to pericyte cultures inhibited the phosphorylation of Axl by endogenous Gas6 and enhanced the rate of nodule mineralization. These effects were inhibited by coincubation of pericytes with Axl-ECD and recombinant Gas6. Together these results demonstrate that activation of Axl inhibits the osteogenic differentiation of vascular pericytes.
Key Words: pericytes calcification osteogenesis Axl receptor tyrosine kinase Gas6
This article has been cited by other articles:
![]() |
R. Mishra and M. S. Simonson Oleate Induces a Myofibroblast-Like Phenotype in Mesangial Cells Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 541 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hutterer, P. Knyazev, A. Abate, M. Reschke, H. Maier, N. Stefanova, T. Knyazeva, V. Barbieri, M. Reindl, A. Muigg, et al. Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme Clin. Cancer Res., January 1, 2008; 14(1): 130 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D.M. Collett, A. P. Sage, J. P. Kirton, M. Y. Alexander, A. P. Gilmore, and A. E. Canfield Axl/Phosphatidylinositol 3-Kinase Signaling Inhibits Mineral Deposition by Vascular Smooth Muscle Cells Circ. Res., March 2, 2007; 100(4): 502 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kirton, F. L. Wilkinson, A. E. Canfield, and M. Y. Alexander Dexamethasone Downregulates Calcification-Inhibitor Molecules and Accelerates Osteogenic Differentiation of Vascular Pericytes: Implications for Vascular Calcification Circ. Res., May 26, 2006; 98(10): 1264 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-K. Son, K. Kozaki, K. Iijima, M. Eto, T. Kojima, H. Ota, Y. Senda, K. Maemura, T. Nakano, M. Akishita, et al. Statins Protect Human Aortic Smooth Muscle Cells From Inorganic Phosphate-Induced Calcification by Restoring Gas6-Axl Survival Pathway Circ. Res., April 28, 2006; 98(8): 1024 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Holland, M. J. Powell, C. Franci, E. W. Chan, A. M. Friera, R. E. Atchison, J. McLaughlin, S. E. Swift, E. S. Pali, G. Yam, et al. Multiple Roles for the Receptor Tyrosine Kinase Axl in Tumor Formation Cancer Res., October 15, 2005; 65(20): 9294 - 9303. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Alexander, F. L. Wilkinson, J. P. Kirton, C. F. Rock, G. D.M. Collett, M. Jeziorska, J. V. Smyth, A. M. Heagerty, and A. E. Canfield Identification and Characterization of Vascular Calcification-Associated Factor, a Novel Gene Upregulated During Vascular Calcification In Vitro and In Vivo Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1851 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.D.M. Collett and A.E. Canfield Angiogenesis and Pericytes in the Initiation of Ectopic Calcification Circ. Res., May 13, 2005; 96(9): 930 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gallicchio, S. Mitola, D. Valdembri, R. Fantozzi, B. Varnum, G. C. Avanzi, and F. Bussolino Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor Blood, March 1, 2005; 105(5): 1970 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Pitera, A. S. Woolf, N. W. Gale, G. D. Yancopoulos, and H. T. Yuan Dysmorphogenesis of Kidney Cortical Peritubular Capillaries in Angiopoietin-2-Deficient Mice Am. J. Pathol., December 1, 2004; 165(6): 1895 - 1906. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Farrington-Rock, N.J. Crofts, M.J. Doherty, B.A. Ashton, C. Griffin-Jones, and A.E. Canfield Chondrogenic and Adipogenic Potential of Microvascular Pericytes Circulation, October 12, 2004; 110(15): 2226 - 2232. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |